
Bong-sook Baek
Examiner (ID: 13827, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1621, 1614, 4161, 1629, 1611 |
| Total Applications | 1174 |
| Issued Applications | 496 |
| Pending Applications | 83 |
| Abandoned Applications | 612 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10169282
[patent_doc_number] => 09199982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Heterocyclylamines as PI3K inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/601349
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 130444
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/601349 | Heterocyclylamines as PI3K inhibitors | Aug 30, 2012 | Issued |
Array
(
[id] => 10339086
[patent_doc_number] => 20150224091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-13
[patent_title] => 'PREVENTION AND TREATMENT OF THROMBOSIS IN MEDICALLY ILL PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 14/241824
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5901
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241824
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241824 | PREVENTION AND TREATMENT OF THROMBOSIS IN MEDICALLY ILL PATIENTS | Aug 29, 2012 | Abandoned |
Array
(
[id] => 10954693
[patent_doc_number] => 20140357715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'ANORECTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/372478
[patent_app_country] => US
[patent_app_date] => 2012-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7131
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14372478
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/372478 | ANORECTIC AGENT | Jul 16, 2012 | Abandoned |
Array
(
[id] => 8477780
[patent_doc_number] => 20120277187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Agent for Preventing Infection'
[patent_app_type] => utility
[patent_app_number] => 13/544748
[patent_app_country] => US
[patent_app_date] => 2012-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4032
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13544748
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/544748 | Agent for Preventing Infection | Jul 8, 2012 | Abandoned |
Array
(
[id] => 8916913
[patent_doc_number] => 20130178538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'Long-Acting Injectable Analgesic Formulations for Animals'
[patent_app_type] => utility
[patent_app_number] => 13/538181
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8148
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13538181
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/538181 | Long-Acting Injectable Analgesic Formulations for Animals | Jun 28, 2012 | Abandoned |
Array
(
[id] => 8892262
[patent_doc_number] => 20130165447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'Inhibitors of PDE10'
[patent_app_type] => utility
[patent_app_number] => 13/531840
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17048
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13531840
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/531840 | Inhibitors of PDE10 | Jun 24, 2012 | Issued |
Array
(
[id] => 10134905
[patent_doc_number] => 09168212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-27
[patent_title] => 'Composition for eyelash growth'
[patent_app_type] => utility
[patent_app_number] => 14/124821
[patent_app_country] => US
[patent_app_date] => 2012-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 2022
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124821
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124821 | Composition for eyelash growth | Jun 7, 2012 | Issued |
| 13/488783 | USE OF mTOR INHIBITORS TO TREAT BACTERIAL INFECTION | Jun 4, 2012 | Abandoned |
Array
(
[id] => 8841091
[patent_doc_number] => 20130136719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/480631
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22369
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13480631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/480631 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | May 24, 2012 | Abandoned |
Array
(
[id] => 11772421
[patent_doc_number] => 09381172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders'
[patent_app_type] => utility
[patent_app_number] => 13/470274
[patent_app_country] => US
[patent_app_date] => 2012-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20635
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470274
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470274 | Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders | May 11, 2012 | Issued |
Array
(
[id] => 8607165
[patent_doc_number] => 20130012477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'DERIVATIVES OF DILLAPIOL AND RELATED MONOLIGNANS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/469870
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5940
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/469870 | Derivatives of dillapiol and related monolignans and use thereof | May 10, 2012 | Issued |
Array
(
[id] => 8516785
[patent_doc_number] => 20120316193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'PROTEOSTASIS REGULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/468757
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37527
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468757 | Proteostasis regulators | May 9, 2012 | Issued |
Array
(
[id] => 8490140
[patent_doc_number] => 20120289547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'COMBINATIONS OF PROPIVERINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER'
[patent_app_type] => utility
[patent_app_number] => 13/468002
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5768
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468002
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468002 | COMBINATIONS OF PROPIVERINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER | May 8, 2012 | Abandoned |
Array
(
[id] => 9662373
[patent_doc_number] => 08809350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 13/464362
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 10
[patent_no_of_words] => 16187
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/464362 | Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases | May 3, 2012 | Issued |
Array
(
[id] => 9135726
[patent_doc_number] => 20130296441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Anti-Obesity Properties of Pterostilbene'
[patent_app_type] => utility
[patent_app_number] => 13/463442
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5986
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463442
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/463442 | Anti-Obesity Properties of Pterostilbene | May 2, 2012 | Abandoned |
Array
(
[id] => 8477829
[patent_doc_number] => 20120277236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'METHOD FOR INHIBITING MMP-9 DIMERIZATION'
[patent_app_type] => utility
[patent_app_number] => 13/457246
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15235
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457246
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457246 | METHOD FOR INHIBITING MMP-9 DIMERIZATION | Apr 25, 2012 | Abandoned |
Array
(
[id] => 9318357
[patent_doc_number] => 20140050696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/114049
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 15024
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114049
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114049 | NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE | Apr 25, 2012 | Abandoned |
Array
(
[id] => 9093872
[patent_doc_number] => 20130273183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => '2-Pyrimidine Thioesters and Thiocarbonates as Skin Brightening Agents'
[patent_app_type] => utility
[patent_app_number] => 13/446240
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6362
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446240 | 2-Pyrimidine Thioesters and Thiocarbonates as Skin Brightening Agents | Apr 12, 2012 | Abandoned |
Array
(
[id] => 9463952
[patent_doc_number] => 20140128379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'NASAL FORMULATIONS OF BENZODIAZEPINE'
[patent_app_type] => utility
[patent_app_number] => 14/007153
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15684
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007153
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007153 | NASAL FORMULATIONS OF BENZODIAZEPINE | Mar 28, 2012 | Abandoned |
Array
(
[id] => 8324502
[patent_doc_number] => 20120196903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => '2-AMINOOXAZOLINES AS TAAR1 LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 13/426736
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43722
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13426736
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/426736 | 2-aminooxazolines as TAAR1 ligands | Mar 21, 2012 | Issued |